BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17985946)

  • 1. Immunoproteasome in Macaca fascicularis: no age-dependent modification of abundance and activity in the brain and insight into an in silico structural model.
    Bellavista E; Mishto M; Santoro A; Bertoni-Freddari C; Sessions RB; Franceschi C
    Rejuvenation Res; 2008 Feb; 11(1):73-82. PubMed ID: 17985946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms.
    Mishto M; Santoro A; Bellavista E; Sessions R; Textoris-Taube K; Dal Piaz F; Carrard G; Forti K; Salvioli S; Friguet B; Kloetzel PM; Rivett AJ; Franceschi C
    Biol Chem; 2006 Apr; 387(4):417-29. PubMed ID: 16606340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.
    Bandoh N; Ogino T; Cho HS; Hur SY; Shen J; Wang X; Kato S; Miyokawa N; Harabuchi Y; Ferrone S
    Tissue Antigens; 2005 Sep; 66(3):185-94. PubMed ID: 16101829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains.
    Mishto M; Bellavista E; Santoro A; Stolzing A; Ligorio C; Nacmias B; Spazzafumo L; Chiappelli M; Licastro F; Sorbi S; Pession A; Ohm T; Grune T; Franceschi C
    Neurobiol Aging; 2006 Jan; 27(1):54-66. PubMed ID: 16298241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related increase in the immunoproteasome content in rat hippocampus: molecular and functional aspects.
    Gavilán MP; Castaño A; Torres M; Portavella M; Caballero C; Jiménez S; García-Martínez A; Parrado J; Vitorica J; Ruano D
    J Neurochem; 2009 Jan; 108(1):260-72. PubMed ID: 19012754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation.
    Basler M; Lauer C; Moebius J; Weber R; Przybylski M; Kisselev AF; Tsu C; Groettrup M
    J Immunol; 2012 Aug; 189(4):1868-77. PubMed ID: 22772448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes.
    Carmony KC; Lee DM; Wu Y; Lee NR; Wehenkel M; Lee J; Lei B; Zhan CG; Kim KB
    Bioorg Med Chem; 2012 Jan; 20(2):607-13. PubMed ID: 21741845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulations.
    Lei B; Abdul Hameed MD; Hamza A; Wehenkel M; Muzyka JL; Yao XJ; Kim KB; Zhan CG
    J Phys Chem B; 2010 Sep; 114(38):12333-9. PubMed ID: 20812720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome function is not impaired in healthy aging of the lung.
    Caniard A; Ballweg K; Lukas C; Yildirim AÖ; Eickelberg O; Meiners S
    Aging (Albany NY); 2015 Oct; 7(10):776-92. PubMed ID: 26540298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Features of immune proteasome expression in the development of rat central nervous system].
    Orlova ASh; Liupina IuV; Abaturova SB; Sharova NP
    Bioorg Khim; 2014; 40(6):703-11. PubMed ID: 25895367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional properties of proteasomes purified from the human kidney.
    Baldovino S; Piccinini M; Anselmino A; Ramondetti C; Rinaudo MT; Costanzo P; Sena LM; Roccatello D
    J Nephrol; 2006; 19(6):710-6. PubMed ID: 17173242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of alpha-type subunits of the Xenopus 20S proteasome and analysis of their changes during the meiotic cell cycle.
    Wakata Y; Tokumoto M; Horiguchi R; Ishikawa K; Nagahama Y; Tokumoto T
    BMC Biochem; 2004 Dec; 5(1):18. PubMed ID: 15603592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i).
    Scheffler S; Kuckelkorn U; Egerer K; Dörner T; Reiter K; Soza A; Burmester GR; Feist E
    Rheumatology (Oxford); 2008 May; 47(5):622-6. PubMed ID: 18375405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive mass spectrometric analysis of the 20S proteasome complex.
    Huang L; Burlingame AL
    Methods Enzymol; 2005; 405():187-236. PubMed ID: 16413316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunoproteasome in antigen processing and other immunological functions.
    Basler M; Kirk CJ; Groettrup M
    Curr Opin Immunol; 2013 Feb; 25(1):74-80. PubMed ID: 23219269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of cerebral cortex and hippocampal proteasome subunit expression and function in a traumatic brain injury rat model.
    Yao X; Liu J; McCabe JT
    J Neurochem; 2008 Jan; 104(2):353-63. PubMed ID: 17944870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence information within proteasomal prosequences mediates efficient integration of beta-subunits into the 20 S proteasome complex.
    Schmidt M; Zantopf D; Kraft R; Kostka S; Preissner R; Kloetzel PM
    J Mol Biol; 1999 Apr; 288(1):117-28. PubMed ID: 10329130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasomes in the brain of β2-microglobulin knockout mice.
    Lyupina YV; Bogatyrev ME; Orlova ASh; Marjukhnich EV; Kazansky DB; Sharova NP
    Biochemistry (Mosc); 2013 Oct; 78(10):1124-33. PubMed ID: 24237146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome.
    Zeng BY; Iravani MM; Lin ST; Irifune M; Kuoppamäki M; Al-Barghouthy G; Smith L; Jackson MJ; Rose S; Medhurst AD; Jenner P
    Eur J Neurosci; 2006 Apr; 23(7):1766-74. PubMed ID: 16623833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders.
    Krause S; Kuckelkorn U; Dörner T; Burmester GR; Feist E; Kloetzel PM
    Ann Rheum Dis; 2006 Aug; 65(8):1021-7. PubMed ID: 16414974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.